T-cell/histiocyte-rich Large B-cell Lymphoma

Overview

Journal Haematologica

Specialty Hematology

Date 2010 Mar 9

PMID 20207840

Citations 15

Authors

Stefania Pittaluga

Elaine S Jaffe

Affiliations

Soon will be listed here.

Citing Articles

Pediatric T-Cell/Histiocyte-Rich Large B-Cell Lymphoma (THRLBC) in an 8-Year-Old Male Child: A Case Report.

Arega G, Adam H, Girma A, Diida G, Beresa E, Adane L Case Rep Oncol Med. 2025; 2025:8869045.

PMID: 40026533 PMC: 11871974. DOI: 10.1155/crom/8869045.

Catch the Calcium: T-Cell Histiocyte-Rich B-Cell Lymphoma Presenting as Hypercalcemia.

Okeke R, Harmon G, Okeke I, Schuler J, Sangappa S, Harmon J World J Oncol. 2023; 14(6):570-574.

PMID: 38022410 PMC: 10681787. DOI: 10.14740/wjon1610.

Epstein-Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma.

Ross A, Leahy C, Neylon F, Steigerova J, Flodr P, Navratilova M Life (Basel). 2023; 13(2).

PMID: 36836878 PMC: 9967091. DOI: 10.3390/life13020521.

Primary splenic T-cell/histiocyte-rich B-cell lymphoma in a patient with recurrent hairy cell leukemia: a case report.

Ahmad T, Al Houri H, Jomaa S, Assad W, Addeen S Oxf Med Case Reports. 2022; 2022(11):omac123.

PMID: 36447474 PMC: 9693827. DOI: 10.1093/omcr/omac123.

The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade.

Tabanelli V, Melle F, Motta G, Mazzara S, Fabbri M, Agostinelli C Blood Adv. 2022; 6(15):4634-4644.

PMID: 35767735 PMC: 9636403. DOI: 10.1182/bloodadvances.2022007046.

References

Kraus M, Haley J . Lymphocyte predominance Hodgkin's disease: the use of bcl-6 and CD57 in diagnosis and differential diagnosis. Am J Surg Pathol. 2000; 24(8):1068-78. DOI: 10.1097/00000478-200008000-00004. View

Franke S, Wlodarska I, Maes B, Vandenberghe P, Delabie J, Hagemeijer A . Lymphocyte predominance Hodgkin disease is characterized by recurrent genomic imbalances. Blood. 2001; 97(6):1845-53. DOI: 10.1182/blood.v97.6.1845. View

Torlakovic E, Tierens A, Dang H, Delabie J . The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease. Am J Pathol. 2001; 159(5):1807-14. PMC: 1867045. DOI: 10.1016/S0002-9440(10)63027-1. View

Achten R, Verhoef G, Vanuytsel L, De Wolf-Peeters C . T-cell/histiocyte-rich large B-cell lymphoma: a distinct clinicopathologic entity. J Clin Oncol. 2002; 20(5):1269-77. DOI: 10.1200/JCO.2002.20.5.1269. View

Achten R, Verhoef G, Vanuytsel L, De Wolf-Peeters C . Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features. Histopathology. 2002; 40(1):31-45. DOI: 10.1046/j.1365-2559.2002.01291.x. View

Rudiger T, Gascoyne R, Jaffe E, de Jong D, Delabie J, De Wolf-Peeters C . Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann Oncol. 2002; 13 Suppl 1:44-51. DOI: 10.1093/annonc/13.s1.44. View

Fraga M, Sanchez-Verde L, Forteza J, Garcia-Rivero A, Piris M . T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma. Histopathology. 2002; 41(3):216-29. DOI: 10.1046/j.1365-2559.2002.01466.x. View

Lim M, Beaty M, Sorbara L, Cheng R, Pittaluga S, Raffeld M . T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells. Am J Surg Pathol. 2002; 26(11):1458-66. DOI: 10.1097/00000478-200211000-00008. View

Franke S, Wlodarska I, Maes B, Vandenberghe P, Achten R, Hagemeijer A . Comparative genomic hybridization pattern distinguishes T-cell/histiocyte-rich B-cell lymphoma from nodular lymphocyte predominance Hodgkin's lymphoma. Am J Pathol. 2002; 161(5):1861-7. PMC: 1850793. DOI: 10.1016/S0002-9440(10)64462-8. View

10.

Wlodarska I, Nooyen P, Maes B, Martin-Subero J, Siebert R, Pauwels P . Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma. Blood. 2002; 101(2):706-10. DOI: 10.1182/blood-2002-05-1592. View

11.

Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke R . Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol. 2003; 27(10):1346-56. DOI: 10.1097/00000478-200310000-00007. View

12.

Boudova L, Torlakovic E, Delabie J, Reimer P, Pfistner B, Wiedenmann S . Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Blood. 2003; 102(10):3753-8. DOI: 10.1182/blood-2003-02-0626. View

13.

Loddenkemper C, Anagnostopoulos I, Hummel M, Johrens-Leder K, Foss H, Jundt F . Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas. J Pathol. 2003; 202(1):60-9. DOI: 10.1002/path.1485. View

14.

Marafioti T, Mancini C, Ascani S, Sabattini E, Zinzani P, Pozzobon M . Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease. Haematologica. 2004; 89(8):957-64. View

15.

Arnold A, Cossman J, Bakhshi A, Jaffe E, Waldmann T, Korsmeyer S . Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med. 1983; 309(26):1593-9. DOI: 10.1056/NEJM198312293092601. View

16.

Ramsay A, Smith W, Isaacson P . T-cell-rich B-cell lymphoma. Am J Surg Pathol. 1988; 12(6):433-43. DOI: 10.1097/00000478-198806000-00003. View

17.

Ng C, Chan J, Hui P, Lau W . Large B-cell lymphomas with a high content of reactive T cells. Hum Pathol. 1989; 20(12):1145-54. DOI: 10.1016/s0046-8177(89)80004-8. View

18.

CHITTAL S, Brousset P, Voigt J, Delsol G . Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease. Histopathology. 1991; 19(3):211-20. DOI: 10.1111/j.1365-2559.1991.tb00024.x. View

19.

Delabie J, Vandenberghe E, Kennes C, Verhoef G, Foschini M, Stul M . Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype. Am J Surg Pathol. 1992; 16(1):37-48. View

20.

Macon W, Williams M, Greer J, Stein R, Collins R, Cousar J . T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 cases. Am J Surg Pathol. 1992; 16(4):351-63. View